Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells
Group3 medulloblastoma (MB G3 ) that predominantly occur in young children are usually associated with MYC amplification and/or overexpression, frequent metastasis and a dismal prognosis. Physiologically relevant MB G3 models are currently lacking, making inferences related to their cellular origin...
Gespeichert in:
Veröffentlicht in: | Oncogene 2017-09, Vol.36 (37), p.5231-5242 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Group3 medulloblastoma (MB
G3
) that predominantly occur in young children are usually associated with
MYC
amplification and/or overexpression, frequent metastasis and a dismal prognosis. Physiologically relevant MB
G3
models are currently lacking, making inferences related to their cellular origin thus far limited. Using
in utero
electroporation, we here report that MB
G3
mouse models can be developed
in situ
from different multipotent embryonic cerebellar progenitor cells via conditional expression of
Myc
and loss of
Trp53
function in several Cre driver mouse lines. The Blbp-Cre driver that targets embryonic neural progenitors induced tumors exhibiting a large-cell/anaplastic histopathology adjacent to the fourth ventricle, recapitulating human MB
G3
. Enforced co-expression of
luciferase
together with
Myc
and a dominant-negative form of Trp53 revealed that GABAergic neuronal progenitors as well as cerebellar granule cells give rise to MB
G3
with their distinct growth kinetics. Cross-species gene expression analysis revealed that these novel MB
G3
models shared molecular characteristics with human MB
G3
, irrespective of their cellular origin. We here developed MB
G3
mouse models in their physiological environment and we show that oncogenic insults drive this MB subgroup in different cerebellar lineages rather than in a specific cell of origin. |
---|---|
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/onc.2017.110 |